💊 医薬品 A-Z 🧬 標的 🛠 ツール 📚 ガイド
全医薬品 薬物分類 治療領域 副作用
ガイド 用語集 年表
比較 薬物の体内の旅 薬物ファミリー
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Vaccinia Virus, Live Modified

CHEMBL6068373 Phase 4 承認済み Vaccine component
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Modified vaccinia Ankara (MVA) is a highly attenuated strain of vaccinia virus created by serial passage in chicken embryo fibroblasts, producing a replication-incompetent virus used as a vaccine vector and smallpox vaccine. It is used as the basis for JYNNEOS/Imvamune, approved for smallpox and monkeypox prevention, and as a vaccine vector platform for HIV, tuberculosis, malaria, and other infectious diseases. Its attenuated nature provides improved safety compared to traditional vaccinia while maintaining strong immunogenicity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Modified vaccinia Ankara (MVA) is a highly attenuated strain of vaccinia virus created by serial passage in chicken embryo fibroblasts, producing a replication-incompetent virus used as a vaccine vector and smallpox vaccine. It is used as the basis for JYNNEOS/Imvamune, approved for smallpox and monkeypox prevention, and as a vaccine vector platform for HIV, tuberculosis, malaria, and other infectious diseases. Its attenuated nature provides improved safety compared to traditional vaccinia while maintaining strong immunogenicity.

Yes, Vaccinia Virus, Live Modified is an approved drug. It has reached clinical phase 4. It is classified as a Vaccine component.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068373. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.